Literature DB >> 22428975

Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods.

Paolo Fagone1, J Fraser Wright, Amit C Nathwani, Arthur W Nienhuis, Andrew M Davidoff, John T Gray.   

Abstract

Self-complementary AAV (scAAV) vector genomes contain a covalently closed hairpin derived from a mutated inverted terminal repeat that connects the two monomer single-stranded genomes into a head-to-head or tail-to-tail dimer. We found that during quantitative PCR (qPCR) this structure inhibits the amplification of proximal amplicons and causes the systemic underreporting of copy number by as much as 10-fold. We show that cleavage of scAAV vector genomes with restriction endonuclease to liberate amplicons from the covalently closed terminal hairpin restores quantitative amplification, and we implement this procedure in a simple, modified qPCR titration method for scAAV vectors. In addition, we developed and present an AAV genome titration procedure based on gel electrophoresis that requires minimal sample processing and has low interassay variability, and as such is well suited for the rigorous quality control demands of clinical vector production facilities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22428975      PMCID: PMC3640491          DOI: 10.1089/hgtb.2011.104

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  11 in total

1.  Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.

Authors:  C L Halbert; T A Standaert; M L Aitken; I E Alexander; D W Russell; A D Miller
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses.

Authors:  K R Clark; X Liu; J P McGrath; P R Johnson
Journal:  Hum Gene Ther       Date:  1999-04-10       Impact factor: 5.695

3.  Surfactant-induced amorphous aggregation of tobacco mosaic virus coat protein: a physical methods approach.

Authors:  Yuliy V Panyukov; Maria A Nemykh; Eugeny N Dobrov; Vladimir A Drachev
Journal:  Macromol Biosci       Date:  2008-02-11       Impact factor: 4.979

4.  Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial.

Authors:  James A Allay; Susan Sleep; Scott Long; David M Tillman; Rob Clark; Gael Carney; Paolo Fagone; Jenny H McIntosh; Arthur W Nienhuis; Andrew M Davidoff; Amit C Nathwani; John T Gray
Journal:  Hum Gene Ther       Date:  2011-05       Impact factor: 5.695

5.  Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material.

Authors:  Martin Lock; Susan McGorray; Alberto Auricchio; Eduard Ayuso; E Jeffrey Beecham; Véronique Blouin-Tavel; Fatima Bosch; Mahuya Bose; Barry J Byrne; Tina Caton; John A Chiorini; Abdelwahed Chtarto; K Reed Clark; Thomas Conlon; Christophe Darmon; Monica Doria; Anne Douar; Terence R Flotte; Joyce D Francis; Achille Francois; Mauro Giacca; Michael T Korn; Irina Korytov; Xavier Leon; Barbara Leuchs; Gabriele Lux; Catherine Melas; Hiroaki Mizukami; Philippe Moullier; Marcus Müller; Keiya Ozawa; Tina Philipsberg; Karine Poulard; Christina Raupp; Christel Rivière; Sigrid D Roosendaal; R Jude Samulski; Steven M Soltys; Richard Surosky; Liliane Tenenbaum; Darby L Thomas; Bart van Montfort; Gabor Veres; J Fraser Wright; Yili Xu; Olga Zelenaia; Lorena Zentilin; Richard O Snyder
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

6.  Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis.

Authors:  D M McCarty; P E Monahan; R J Samulski
Journal:  Gene Ther       Date:  2001-08       Impact factor: 5.250

7.  Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression.

Authors:  R J Samulski; L S Chang; T Shenk
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

8.  Quantification of adeno-associated virus particles and empty capsids by optical density measurement.

Authors:  Jürg M Sommer; Peter H Smith; Sumathy Parthasarathy; Jesse Isaacs; Sharmila Vijay; Jane Kieran; Sharon K Powell; Alan McClelland; J Fraser Wright
Journal:  Mol Ther       Date:  2003-01       Impact factor: 11.454

9.  Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo.

Authors:  Z Wang; H-I Ma; J Li; L Sun; J Zhang; X Xiao
Journal:  Gene Ther       Date:  2003-12       Impact factor: 5.250

10.  Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.

Authors:  D M McCarty; H Fu; P E Monahan; C E Toulson; P Naik; R J Samulski
Journal:  Gene Ther       Date:  2003-12       Impact factor: 5.250

View more
  41 in total

1.  Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR.

Authors:  Martin Lock; Mauricio R Alvira; Shu-Jen Chen; James M Wilson
Journal:  Hum Gene Ther Methods       Date:  2014-02-14       Impact factor: 2.396

2.  Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation.

Authors:  Yuan Wang; Chen Ling; Liujiang Song; Lina Wang; George V Aslanidi; Mengqun Tan; Changquan Ling; Arun Srivastava
Journal:  Hum Gene Ther Methods       Date:  2012-08       Impact factor: 2.396

3.  Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.

Authors:  Marina O'Reilly; Donald B Kohn; Jeffrey Bartlett; Janet Benson; Philip J Brooks; Barry J Byrne; Carlos Camozzi; Kenneth Cornetta; Ronald G Crystal; Yuman Fong; Linda Gargiulo; Rashmi Gopal-Srivastava; Katherine A High; Samuel G Jacobson; Robert C Jambou; Maureen Montgomery; Eugene Rosenthal; R Jude Samulski; Sonia I Skarlatos; Brian Sorrentino; James M Wilson; Yun Xie; Jacqueline Corrigan-Curay
Journal:  Hum Gene Ther       Date:  2013-04       Impact factor: 5.695

4.  Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gels.

Authors:  Erik Kohlbrenner; Els Henckaerts; Kleopatra Rapti; Ronald E Gordon; R Michael Linden; Roger J Hajjar; Thomas Weber
Journal:  Hum Gene Ther Methods       Date:  2012-07-20       Impact factor: 2.396

Review 5.  Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.

Authors:  Pasqualina Colella; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2012-08       Impact factor: 5.695

6.  Synthetic certified DNA reference material for analysis of human erythropoietin transgene and transcript in gene doping and gene therapy.

Authors:  A Baoutina; S Bhat; M Zheng; L Partis; M Dobeson; I E Alexander; K R Emslie
Journal:  Gene Ther       Date:  2016-06-07       Impact factor: 5.250

7.  Overexpression of Nudt7 decreases bile acid levels and peroxisomal fatty acid oxidation in the liver.

Authors:  Stephanie A Shumar; Evan W Kerr; Paolo Fagone; Aniello M Infante; Roberta Leonardi
Journal:  J Lipid Res       Date:  2019-03-07       Impact factor: 5.922

8.  Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.

Authors:  Derek Leaderer; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  J Gene Med       Date:  2015 Jun-Jul       Impact factor: 4.565

9.  Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.

Authors:  Jenny McIntosh; Peter J Lenting; Cecilia Rosales; Doyoung Lee; Samira Rabbanian; Deepak Raj; Nishil Patel; Edward G D Tuddenham; Olivier D Christophe; John H McVey; Simon Waddington; Arthur W Nienhuis; John T Gray; Paolo Fagone; Federico Mingozzi; Shang-Zhen Zhou; Katherine A High; Maria Cancio; Catherine Y C Ng; Junfang Zhou; Christopher L Morton; Andrew M Davidoff; Amit C Nathwani
Journal:  Blood       Date:  2013-02-20       Impact factor: 22.113

Review 10.  Adeno-associated viral vectors for the treatment of hemophilia.

Authors:  Katherine A High; Xavier M Anguela
Journal:  Hum Mol Genet       Date:  2015-11-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.